AwardedCzechiaGoodsCZK 28,416,518
Dodávky léků – Léčivá látka vedolizumab – ATC L04AG05
- Published
- Published 3 March 2026
- Deadline
- Closed 2 April 2026
Overview
Předmětem plnění Veřejné zakázky jsou průběžné dodávky léčivého přípravku s obsahem léčivé látky vedolizumab – ATC L04AG05.
LL - vedolizumab, léková forma 300MG INF PLV CSL, měrná jednotka 1X300MG, množství 400
LL - vedolizumab, léková forma 108MG INJ SOL PEP, měrná jednotka 1X0,68ML, množství 2 300
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 28,416,518
- Procedure
- Open
- SME suitable
- Yes
- Published
- 3 March 2026
- Deadline
- Closed
Immunosuppressive agents
Award outcome
- Awarded value
- CZK 28,416,518
- Award date
- 9 April 2026
- Contract period
- 17 April 2026 → 27 March 2030
- Takeda Pharmaceuticals Czech Republic s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
21 April 2026
Contract Notice
3 March 2026
Contracting authority
Fakultní Thomayerova nemocnice
Procuring entityPraha, Czechia
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.